{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T14:12:36Z","timestamp":1758809556550},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"This study was supported in part by a research grant from the Research Committee of the University of Thessaly, Greece (code 5287).","award":["5287"],"award-info":[{"award-number":["5287"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s12031-020-01553-4","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T22:03:44Z","timestamp":1589839424000},"page":"1370-1375","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["CYP1A2 rs762551 and ADORA2A rs5760423 Polymorphisms in Patients with Blepharospasm"],"prefix":"10.1007","volume":"70","author":[{"given":"Vasileios","family":"Siokas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Kardaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina-Maria","family":"Aloizou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Liampas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Drakoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristidis","family":"Tsatsakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayiotis D.","family":"Mitsias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios M.","family":"Hadjigeorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia E.","family":"Tsironi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthimios","family":"Dardiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"key":"1553_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/mds.25475","volume":"28","author":"A Albanese","year":"2013","unstructured":"Albanese A et al (2013) Phenomenology and classification of dystonia: a consensus update. Mov Disord 28:863\u2013873. https:\/\/doi.org\/10.1002\/mds.25475","journal-title":"Mov Disord"},{"key":"1553_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ene.13762","volume":"26","author":"A Albanese","year":"2019","unstructured":"Albanese A, Di Giovanni M, Lalli S (2019) Dystonia: diagnosis and management. Eur J Neurol 26:5\u201317. https:\/\/doi.org\/10.1111\/ene.13762","journal-title":"Eur J Neurol"},{"key":"1553_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.toxlet.2020.03.005","volume":"326","author":"AM Aloizou","year":"2020","unstructured":"Aloizou AM et al (2020) Pesticides, cognitive functions and dementia: a review. Toxicol Lett 326:31\u201351. https:\/\/doi.org\/10.1016\/j.toxlet.2020.03.005","journal-title":"Toxicol Lett"},{"key":"1553_CR4","doi-asserted-by":"publisher","first-page":"Rc143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","volume":"21","author":"JF Chen","year":"2001","unstructured":"Chen JF et al (2001) Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson\u2019s disease. J Neurosci 21:Rc143","journal-title":"J Neurosci"},{"key":"1553_CR5","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000450855","volume":"47","author":"YH Chuang","year":"2016","unstructured":"Chuang YH et al (2016) Gene-environment interaction in Parkinson\u2019s disease: coffee, ADORA2A, and CYP1A2. Neuroepidemiology 47:192\u2013200. https:\/\/doi.org\/10.1159\/000450855","journal-title":"Neuroepidemiology"},{"key":"1553_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/fpc.0000000000000161","volume":"25","author":"E Dardiotis","year":"2015","unstructured":"Dardiotis E et al (2015) Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury. Pharmacogenet Genomics 25:485\u2013490. https:\/\/doi.org\/10.1097\/fpc.0000000000000161","journal-title":"Pharmacogenet Genomics"},{"key":"1553_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12017-016-8429-3","volume":"19","author":"E Dardiotis","year":"2017","unstructured":"Dardiotis E et al (2017) Integrins AV and B8 gene polymorphisms and risk for intracerebral hemorrhage in Greek and Polish populations. Neuromolecular Med 19:69\u201380. https:\/\/doi.org\/10.1007\/s12017-016-8429-3","journal-title":"Neuromolecular Med"},{"key":"1553_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.envint.2018.04.008","volume":"116","author":"E Dardiotis","year":"2018","unstructured":"Dardiotis E et al (2018) Genetic polymorphisms in amyotrophic lateral sclerosis: evidence for implication in detoxification pathways of environmental toxicants. Environ Int 116:122\u2013135. https:\/\/doi.org\/10.1016\/j.envint.2018.04.008","journal-title":"Environ Int"},{"key":"1553_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1136\/jnnp.2007.119891","volume":"78","author":"G Defazio","year":"2007","unstructured":"Defazio G et al (2007) Influence of coffee drinking and cigarette smoking on the risk of primary late onset blepharospasm: evidence from a multicentre case control study. J Neurol Neurosurg Psychiatry 78:877\u2013879. https:\/\/doi.org\/10.1136\/jnnp.2007.119891","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1553_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1212\/WNL.0b013e31829bfdf6","volume":"81","author":"G Defazio","year":"2013","unstructured":"Defazio G, Hallett M, Jinnah HA, Berardelli A (2013) Development and validation of a clinical guideline for diagnosing blepharospasm. Neurology 81:236\u2013240. https:\/\/doi.org\/10.1212\/WNL.0b013e31829bfdf6","journal-title":"Neurology"},{"key":"1553_CR11","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/mds.26934","volume":"32","author":"G Defazio","year":"2017","unstructured":"Defazio G, Hallett M, Jinnah HA, Conte A, Berardelli A (2017) Blepharospasm 40 years later. Mov Disord 32:498\u2013509. https:\/\/doi.org\/10.1002\/mds.26934","journal-title":"Mov Disord"},{"key":"1553_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10072-018-3586-9","volume":"40","author":"G Defazio","year":"2019","unstructured":"Defazio G et al (2019) Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia. Neurol Sci 40:89\u201395. https:\/\/doi.org\/10.1007\/s10072-018-3586-9","journal-title":"Neurol Sci"},{"key":"1553_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.toxrep.2017.05.007","volume":"4","author":"AO Docea","year":"2017","unstructured":"Docea AO et al (2017) CYP polymorphisms and pathological conditions related to chronic exposure to organochlorine pesticides. Toxicol Rep 4:335\u2013341. https:\/\/doi.org\/10.1016\/j.toxrep.2017.05.007","journal-title":"Toxicol Rep"},{"key":"1553_CR14","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3389\/fneur.2019.01387","volume":"10","author":"H Dong","year":"2019","unstructured":"Dong H, Luo Y, Fan S, Yin B, Weng C, Peng B (2019) Screening Gene Mutations in Chinese Patients With Benign Essential Blepharospasm. Front Neurol 10:1387. https:\/\/doi.org\/10.3389\/fneur.2019.01387","journal-title":"Front Neurol"},{"key":"1553_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/mds.24922","volume":"27","author":"JL Groen","year":"2012","unstructured":"Groen JL et al (2012) Association of BDNF Met66Met polymorphism with arm tremor in cervical dystonia. Mov Disord 27:796\u2013797. https:\/\/doi.org\/10.1002\/mds.24922","journal-title":"Mov Disord"},{"key":"1553_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2217\/14622416.9.5.625","volume":"9","author":"A Gunes","year":"2008","unstructured":"Gunes A, Dahl ML (2008) Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics 9:625\u2013637. https:\/\/doi.org\/10.2217\/14622416.9.5.625","journal-title":"Pharmacogenomics"},{"key":"1553_CR17","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1212\/01.wnl.0000327601.46315.85","volume":"71","author":"M Hallett","year":"2008","unstructured":"Hallett M, Evinger C, Jankovic J, Stacy M (2008) Update on blepharospasm: report from the BEBRF International Workshop. Neurology 71:1275\u20131282. https:\/\/doi.org\/10.1212\/01.wnl.0000327601.46315.85","journal-title":"Neurology"},{"key":"1553_CR18","doi-asserted-by":"publisher","unstructured":"Hammer M, Abravanel A, Peckham E, Mahloogi A, Majounie E, Hallett M, Singleton A (2019) Blepharospasm: a genetic screening study in 132 patients. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.04.003","DOI":"10.1016\/j.parkreldis.2019.04.003"},{"key":"1553_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neurobiolaging.2017.08.010","volume":"60","author":"E Horgusluoglu-Moloch","year":"2017","unstructured":"Horgusluoglu-Moloch E et al (2017) Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer\u2019s disease. Neurobiol Aging 60:92\u2013103. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2017.08.010","journal-title":"Neurobiol Aging"},{"key":"1553_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00702-019-02030-y","volume":"126","author":"KA Jellinger","year":"2019","unstructured":"Jellinger KA (2019) Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update. II. Hyperkinetic disorders. J Neural Transm (Vienna) 126:997\u20131027. https:\/\/doi.org\/10.1007\/s00702-019-02030-y","journal-title":"J Neural Transm (Vienna)"},{"key":"1553_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.7916\/d8v69x3s","volume":"7","author":"HA Jinnah","year":"2017","unstructured":"Jinnah HA, Neychev V, Hess EJ (2017) The anatomical basis for dystonia: the motor network model. Tremor Other Hyperkinet Mov (N Y) 7:506. https:\/\/doi.org\/10.7916\/d8v69x3s","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"1553_CR22","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41397-017-0011-3","volume":"18","author":"N Koonrungsesomboon","year":"2018","unstructured":"Koonrungsesomboon N, Khatsri R, Wongchompoo P, Teekachunhatean S (2018) The impact of genetic polymorphisms on CYP1A2 activity in humans: a systematic review and meta-analysis. Pharm J 18:760\u2013768. https:\/\/doi.org\/10.1038\/s41397-017-0011-3","journal-title":"Pharm J"},{"key":"1553_CR23","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/jnnp.39.12.1204","volume":"39","author":"CD Marsden","year":"1976","unstructured":"Marsden CD (1976) Blepharospasm-oromandibular dystonia syndrome (Brueghel\u2019s syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry 39:1204\u20131209","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1553_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12031-018-1220-1","volume":"67","author":"TGM Nery","year":"2019","unstructured":"Nery TGM, Silva EM, Tavares R, Passetti F (2019) The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach. J Mol Neurosci 67:150\u2013164. https:\/\/doi.org\/10.1007\/s12031-018-1220-1","journal-title":"J Mol Neurosci"},{"key":"1553_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2018.07.018","volume":"57","author":"O Ohlei","year":"2018","unstructured":"Ohlei O, Dobricic V, Lohmann K, Klein C, Lill CM, Bertram L (2018) Field synopsis and systematic meta-analyses of genetic association studies in isolated dystonia. Parkinsonism Relat Disord 57:50\u201357. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.07.018","journal-title":"Parkinsonism Relat Disord"},{"key":"1553_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.parkreldis.2010.02.012","volume":"16","author":"N Palacios","year":"2010","unstructured":"Palacios N, Weisskopf M, Simon K, Gao X, Schwarzschild M, Ascherio A (2010) Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson\u2019s disease in men and women. Parkinsonism Relat Disord 16:370\u2013375. https:\/\/doi.org\/10.1016\/j.parkreldis.2010.02.012","journal-title":"Parkinsonism Relat Disord"},{"key":"1553_CR27","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1080\/17460441.2019.1623785","volume":"14","author":"S Pirio Richardson","year":"2019","unstructured":"Pirio Richardson S, Jinnah HA (2019) New approaches to discovering drugs that treat dystonia. Expert Opin Drug Discov 14:893\u2013900. https:\/\/doi.org\/10.1080\/17460441.2019.1623785","journal-title":"Expert Opin Drug Discov"},{"key":"1553_CR28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/j.1468-1331.2011.03353.x","volume":"18","author":"RA Popat","year":"2011","unstructured":"Popat RA et al (2011) Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson\u2019s disease. Eur J Neurol 18:756\u2013765. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03353.x","journal-title":"Eur J Neurol"},{"key":"1553_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1326-8-19","volume":"8","author":"S Rayaprolu","year":"2013","unstructured":"Rayaprolu S et al (2013) TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease. Mol Neurodegener 8:19. https:\/\/doi.org\/10.1186\/1750-1326-8-19","journal-title":"Mol Neurodegener"},{"key":"1553_CR30","doi-asserted-by":"publisher","first-page":"108637","DOI":"10.1016\/j.envres.2019.108637","volume":"177","author":"JA Ruszkiewicz","year":"2019","unstructured":"Ruszkiewicz JA, Tinkov AA, Skalny AV, Siokas V, Dardiotis E, Tsatsakis A, Bowman AB, da Rocha JBT, Aschner M (2019) Brain diseases in changing climate. Environ Res 177:108637. https:\/\/doi.org\/10.1016\/j.envres.2019.108637","journal-title":"Environ Res"},{"key":"1553_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1365-2125.1999.00898.x","volume":"47","author":"C Sachse","year":"1999","unstructured":"Sachse C, Brockmoller J, Bauer S, Roots I (1999) Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47:445\u2013449","journal-title":"Br J Clin Pharmacol"},{"key":"1553_CR32","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1093\/hmg\/ddi351","volume":"14","author":"M Sardiello","year":"2005","unstructured":"Sardiello M, Annunziata I, Roma G, Ballabio A (2005) Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship. Hum Mol Genet 14:3203\u20133217. https:\/\/doi.org\/10.1093\/hmg\/ddi351","journal-title":"Hum Mol Genet"},{"key":"1553_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.7916\/d8-j6sx-b156","volume":"9","author":"N Sharma","year":"2019","unstructured":"Sharma N (2019) Neuropathology of dystonia. Tremor Other Hyperkinet Mov (N Y) 9:569. https:\/\/doi.org\/10.7916\/d8-j6sx-b156","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"1553_CR34","doi-asserted-by":"publisher","first-page":"104462","DOI":"10.1016\/j.nbd.2019.05.001","volume":"132","author":"AS Shetty","year":"2019","unstructured":"Shetty AS, Bhatia KP, Lang AE (2019) Dystonia and Parkinson\u2019s disease: what is the relationship? Neurobiol Dis 132:104462. https:\/\/doi.org\/10.1016\/j.nbd.2019.05.001","journal-title":"Neurobiol Dis"},{"key":"1553_CR35","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1080\/02713683.2016.1276197","volume":"42","author":"V Siokas","year":"2017","unstructured":"Siokas V et al (2017a) Plasminogen activator inhibitor type-1 tag single-nucleotide polymorphisms in patients with diabetes mellitus type 2 and diabetic retinopathy. Curr Eye Res 42:1048\u20131053. https:\/\/doi.org\/10.1080\/02713683.2016.1276197","journal-title":"Curr Eye Res"},{"key":"1553_CR36","doi-asserted-by":"publisher","first-page":"e0169934","DOI":"10.1371\/journal.pone.0169934","volume":"12","author":"V Siokas","year":"2017","unstructured":"Siokas V et al (2017b) The role of TOR1A polymorphisms in dystonia: a systematic review and meta-analysis. PLoS One 12:e0169934. https:\/\/doi.org\/10.1371\/journal.pone.0169934","journal-title":"PLoS One"},{"key":"1553_CR37","doi-asserted-by":"publisher","unstructured":"Siokas V et al (2017c) SLC2A1 tag SNPs in Greek patients with diabetic retinopathy and nephropathy. Ophthalmic Res. https:\/\/doi.org\/10.1159\/000480241","DOI":"10.1159\/000480241"},{"key":"1553_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.7916\/d8h438gs","volume":"8","author":"V Siokas","year":"2018","unstructured":"Siokas V, Aloizou AM, Tsouris Z, Michalopoulou A, Mentis AA, Dardiotis E (2018) Risk factor genes in patients with dystonia: a comprehensive review. Tremor Other Hyperkinet Mov (N Y) 8:559. https:\/\/doi.org\/10.7916\/d8h438gs","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"1553_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s12017-018-8519-5","volume":"21","author":"V Siokas","year":"2019","unstructured":"Siokas V et al (2019a) BDNF rs6265 (Val66Met) polymorphism as a risk factor for blepharospasm. Neuromolecular Med 21:68\u201374. https:\/\/doi.org\/10.1007\/s12017-018-8519-5","journal-title":"Neuromolecular Med"},{"key":"1553_CR40","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s12031-018-1255-3","volume":"67","author":"V Siokas","year":"2019","unstructured":"Siokas V et al (2019b) Lack of association of the rs11655081 ARSG gene with blepharospasm. J Mol Neurosci 67:472\u2013476. https:\/\/doi.org\/10.1007\/s12031-018-1255-3","journal-title":"J Mol Neurosci"},{"key":"1553_CR41","doi-asserted-by":"publisher","unstructured":"Siokas V, Aslanidou P, Aloizou AM, Peristeri E, Stamati P, Liampas I, Arseniou S, Drakoulis N, Aschner M, Tsatsakis A, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E (2020) Does the CD33 rs3865444 polymorphism confer susceptibility to Alzheimer\u2019s disease? J Mol Neurosci. https:\/\/doi.org\/10.1007\/s12031-020-01507-w","DOI":"10.1007\/s12031-020-01507-w"},{"key":"1553_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/ng1706","volume":"38","author":"AD Skol","year":"2006","unstructured":"Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38:209\u2013213. https:\/\/doi.org\/10.1038\/ng1706","journal-title":"Nat Genet"},{"key":"1553_CR43","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","volume":"22","author":"X Sole","year":"2006","unstructured":"Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928\u20131929. https:\/\/doi.org\/10.1093\/bioinformatics\/btl268","journal-title":"Bioinformatics"},{"key":"1553_CR44","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/mds.25244","volume":"27","author":"TD Steeves","year":"2012","unstructured":"Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T (2012) The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord 27:1789\u20131796. https:\/\/doi.org\/10.1002\/mds.25244","journal-title":"Mov Disord"},{"key":"1553_CR45","doi-asserted-by":"publisher","unstructured":"Tian J et al (2018) Whole-exome sequencing for variant discovery in blepharospasm. Mol Genet Genomic Med. https:\/\/doi.org\/10.1002\/mgg3.411","DOI":"10.1002\/mgg3.411"},{"key":"1553_CR46","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/0960327116681652","volume":"36","author":"AM Tsatsakis","year":"2017","unstructured":"Tsatsakis AM et al (2017) Simulating real-life exposures to uncover possible risks to human health: a proposed consensus for a novel methodological approach. Hum Exp Toxicol 36:554\u2013564. https:\/\/doi.org\/10.1177\/0960327116681652","journal-title":"Hum Exp Toxicol"},{"key":"1553_CR47","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.toxrep.2018.10.001","volume":"5","author":"AM Tsatsakis","year":"2018","unstructured":"Tsatsakis AM et al (2018) The dose response principle from philosophy to modern toxicology: the impact of ancient philosophy and medicine in modern toxicology science. Toxicol Rep 5:1107\u20131113. https:\/\/doi.org\/10.1016\/j.toxrep.2018.10.001","journal-title":"Toxicol Rep"},{"key":"1553_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.fct.2018.12.043","volume":"125","author":"AM Tsatsakis","year":"2019","unstructured":"Tsatsakis AM et al (2019) Hormetic neurobehavioral effects of low dose toxic chemical mixtures in real-life risk simulation (RLRS) in rats. Food Chem Toxicol 125:141\u2013149. https:\/\/doi.org\/10.1016\/j.fct.2018.12.043","journal-title":"Food Chem Toxicol"},{"key":"1553_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fneur.2016.00045","volume":"7","author":"J Valls-Sole","year":"2016","unstructured":"Valls-Sole J, Defazio G (2016) Blepharospasm: update on epidemiology, clinical aspects, and pathophysiology. Front Neurol 7:45. https:\/\/doi.org\/10.3389\/fneur.2016.00045","journal-title":"Front Neurol"},{"key":"1553_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jphs.2019.01.006","volume":"139","author":"T Yoshihara","year":"2019","unstructured":"Yoshihara T et al (2019) Influence of genetic polymorphisms and habitual caffeine intake on the changes in blood pressure, pulse rate, and calculation speed after caffeine intake: a prospective, double blind, randomized trial in healthy volunteers. J Pharmacol Sci 139:209\u2013214. https:\/\/doi.org\/10.1016\/j.jphs.2019.01.006","journal-title":"J Pharmacol Sci"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01553-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-020-01553-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-020-01553-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T23:06:23Z","timestamp":1621292783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-020-01553-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["1553"],"URL":"https:\/\/doi.org\/10.1007\/s12031-020-01553-4","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"21 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research study was approved by the Local Ethics Committee and was performed according to the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}